EuroIntervention 2014;10:74-82 published online ahead of print December 2013. DOI: 10.4244/EIJV10I1A13
Aims: Patients with diabetes mellitus have a higher risk of adverse events after percutaneous coronary intervention (PCI). This study aimed to elucidate the relative efficacy of everolimu
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com